Cases of avian influenza A (H5N1) continue to rise among cattle and humans in the USA.
Scientists and government health officials are preparing for the potential of the virus adapting to enable human-to-human transmission.
While there is no evidence yet that H5N1 could spread between humans, pandemic preparedness is essential, and mRNA vaccines offer great potential to mitigate a future pandemic, according to GlobalData, the data and analytics company.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze